Viral Activation Transfusion Study (VATS)
Not Applicable
Completed
- Conditions
- Acquired Immunodeficiency SyndromeHIV InfectionsBlood TransfusionCytomegalovirus Infections
Optimal Exercise Regimens for Persons at Increased Risk
Phase 2
Completed
- Conditions
- Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular Diseases
Raynaud's Treatment Study (RTS)
Phase 3
Completed
- Conditions
- Raynaud's DiseaseVascular DiseasesCardiovascular DiseasesHeart Diseases
Studies of Left Ventricular Dysfunction (SOLVD)
Phase 3
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesHypertensionHeart FailureMyocardial IschemiaCoronary Disease
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Phase 3
Completed
- Conditions
- Disease Transmission, VerticalAcquired Immunodeficiency SyndromeHIV Infections
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Phase 3
Completed
- Conditions
- HypercholesterolemiaDiabetes Mellitus, Type 2HypertensionDiabetes MellitusCoronary DiseaseAtherosclerosisCardiovascular Diseases
- Interventions
- Drug: Anti-hyperglycemic AgentsDrug: Anti-hypertensive Agents
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-11-22
- Target Recruit Count
- 10251
- Registration Number
- NCT00000620
- Locations
- 🇺🇸
Minneapolis Medical Research Foundation, Minneapolis, Minnesota, United States
🇺🇸Columbia University, New York, New York, United States
🇺🇸Wake Forest University, Winston-Salem, North Carolina, United States
Inhaled Beclomethasone to Prevent Chronic Lung Disease
Phase 3
Completed
- Conditions
- Bronchopulmonary DysplasiaHyaline Membrane DiseaseLung Diseases